A citation-based method for searching scientific literature

Maria Teresa Landi, Jürgen Bauer, Ruth M Pfeiffer, David E Elder, Benjamin Hulley, Paola Minghetti, Donato Calista, Peter A Kanetsky, Daniel Pinkel, Boris C Bastian. Science 2006
Times Cited: 238







List of co-cited articles
843 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MC1R variants increase risk of melanomas harboring BRAF mutations.
Maria Concetta Fargnoli, Kris Pike, Ruth M Pfeiffer, Shirley Tsang, Ester Rozenblum, David J Munroe, Yelena Golubeva, Donato Calista, Stefania Seidenari, Daniela Massi,[...]. J Invest Dermatol 2008
66
45

Distinct sets of genetic alterations in melanoma.
John A Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N Patel, Klaus J Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E LeBoit,[...]. N Engl J Med 2005
29

The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population.
Elke Hacker, Nicholas K Hayward, Troy Dumenil, Michael R James, David C Whiteman. J Invest Dermatol 2010
67
35

Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.
David C Whiteman, Peter Watt, David M Purdie, Maria Celia Hughes, Nicholas K Hayward, Adèle C Green. J Natl Cancer Inst 2003
288
19

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
19

A landscape of driver mutations in melanoma.
Eran Hodis, Ian R Watson, Gregory V Kryukov, Stefan T Arold, Marcin Imielinski, Jean-Philippe Theurillat, Elizabeth Nickerson, Daniel Auclair, Liren Li, Chelsea Place,[...]. Cell 2012
19

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
18

Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors.
Dominique Scherer, P Sivaramakrishna Rachakonda, Sabrina Angelini, Franziska Mehnert, Antje Sucker, Friederike Egberts, Axel Hauschild, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar. J Invest Dermatol 2010
22
77

High frequency of BRAF mutations in nevi.
Pamela M Pollock, Ursula L Harper, Katherine S Hansen, Laura M Yudt, Mitchell Stark, Christiane M Robbins, Tracy Y Moses, Galen Hostetter, Urs Wagner, John Kakareka,[...]. Nat Genet 2003
17

An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Devarati Mitra, Xi Luo, Ann Morgan, Jin Wang, Mai P Hoang, Jennifer Lo, Candace R Guerrero, Jochen K Lennerz, Martin C Mihm, Jennifer A Wargo,[...]. Nature 2012
277
17

Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.
Nancy E Thomas, Peter A Kanetsky, Sharon N Edmiston, Audrey Alexander, Colin B Begg, Pamela A Groben, Honglin Hao, Klaus Busam, David W Ollila, Marianne Berwick,[...]. J Invest Dermatol 2010
26
61

NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.
Elke Hacker, Eduardo Nagore, Lorenzo Cerroni, Susan L Woods, Nicholas K Hayward, Brett Chapman, Grant W Montgomery, H Peter Soyer, David C Whiteman. J Invest Dermatol 2013
30
53

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
16

MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
Sara Raimondi, Francesco Sera, Sara Gandini, Simona Iodice, Saverio Caini, Patrick Maisonneuve, Maria Concetta Fargnoli. Int J Cancer 2008
233
15


Improving melanoma classification by integrating genetic and morphologic features.
Amaya Viros, Jane Fridlyand, Juergen Bauer, Konstantin Lasithiotakis, Claus Garbe, Daniel Pinkel, Boris C Bastian. PLoS Med 2008
250
15

Determinants of BRAF mutations in primary melanomas.
Janet L Maldonado, Jane Fridlyand, Hetal Patel, Ajay N Jain, Klaus Busam, Toshiro Kageshita, Tomomichi Ono, Donna G Albertson, Dan Pinkel, Boris C Bastian. J Natl Cancer Inst 2003
469
14

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?
J S Palmer, D L Duffy, N F Box, J F Aitken, L E O'Gorman, A C Green, N K Hayward, N G Martin, R A Sturm. Am J Hum Genet 2000
385
14

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
Georgina V Long, Alexander M Menzies, Adnan M Nagrial, Lauren E Haydu, Anne L Hamilton, Graham J Mann, T Michael Hughes, John F Thompson, Richard A Scolyer, Richard F Kefford. J Clin Oncol 2011
740
14

Somatic activation of KIT in distinct subtypes of melanoma.
John A Curtin, Klaus Busam, Daniel Pinkel, Boris C Bastian. J Clin Oncol 2006
14

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
13

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Michael Krauthammer, Yong Kong, Byung Hak Ha, Perry Evans, Antonella Bacchiocchi, James P McCusker, Elaine Cheng, Matthew J Davis, Gerald Goh, Murim Choi,[...]. Nat Genet 2012
805
13


Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.
David L Duffy, Neil F Box, Wei Chen, James S Palmer, Grant W Montgomery, Michael R James, Nicholas K Hayward, Nicholas G Martin, Richard A Sturm. Hum Mol Genet 2004
193
12


Clinical correlates of NRAS and BRAF mutations in primary human melanoma.
Julie A Ellerhorst, Victoria R Greene, Suhendan Ekmekcioglu, Carla L Warneke, Marcella M Johnson, Carolyn P Cooke, Li-E Wang, Victor G Prieto, Jeffrey E Gershenwald, Qingyi Wei,[...]. Clin Cancer Res 2011
177
11

Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes.
Ana Luisa Kadekaro, Juping Chen, Jennifer Yang, Shuna Chen, Joshua Jameson, Viki B Swope, Tan Cheng, Madhavi Kadakia, Zalfa Abdel-Malek. Mol Cancer Res 2012
90
12

From melanocytes to melanomas.
A Hunter Shain, Boris C Bastian. Nat Rev Cancer 2016
353
11

Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.
Nancy E Thomas, Sharon N Edmiston, Audrey Alexander, Robert C Millikan, Pamela A Groben, Honglin Hao, Dawn Tolbert, Marianne Berwick, Klaus Busam, Colin B Begg,[...]. Cancer Epidemiol Biomarkers Prev 2007
145
10

BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site.
Jürgen Bauer, Petra Büttner, Rajmohan Murali, Ichiro Okamoto, Nicholas A Kolaitis, Maria T Landi, Richard A Scolyer, Boris C Bastian. Pigment Cell Melanoma Res 2011
149
10

Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Peter A Kanetsky, Timothy R Rebbeck, Amanda J Hummer, Saarene Panossian, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton Culver,[...]. Cancer Res 2006
96
9

Melanocortin-1 receptor structure and functional regulation.
José C García-Borrón, Berta L Sánchez-Laorden, Celia Jiménez-Cervantes. Pigment Cell Res 2005
237
9

Inhibition of mutated, activated BRAF in metastatic melanoma.
Keith T Flaherty, Igor Puzanov, Kevin B Kim, Antoni Ribas, Grant A McArthur, Jeffrey A Sosman, Peter J O'Dwyer, Richard J Lee, Joseph F Grippo, Keith Nolop,[...]. N Engl J Med 2010
9

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
Jeffrey A Sosman, Kevin B Kim, Lynn Schuchter, Rene Gonzalez, Anna C Pavlick, Jeffrey S Weber, Grant A McArthur, Thomas E Hutson, Stergios J Moschos, Keith T Flaherty,[...]. N Engl J Med 2012
9

Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.
Wendy Liu, John W Kelly, Melanie Trivett, William K Murray, John P Dowling, Rory Wolfe, Graham Mason, Jill Magee, Christopher Angel, Alexander Dobrovic,[...]. J Invest Dermatol 2007
150
9

MC1R is a potent regulator of PTEN after UV exposure in melanocytes.
Juxiang Cao, Lixin Wan, Elke Hacker, Xiangpeng Dai, Stefania Lenna, Celia Jimenez-Cervantes, Yongjun Wang, Nick R Leslie, George X Xu, Hans R Widlund,[...]. Mol Cell 2013
97
9


alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes.
Ana Luisa Kadekaro, Renny Kavanagh, Hiromi Kanto, Silva Terzieva, Jennifer Hauser, Nobuhiko Kobayashi, Sandy Schwemberger, James Cornelius, George Babcock, Howard G Shertzer,[...]. Cancer Res 2005
193
8

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.
Catherine D Van Raamsdonk, Vladimir Bezrookove, Gary Green, Jürgen Bauer, Lona Gaugler, Joan M O'Brien, Elizabeth M Simpson, Gregory S Barsh, Boris C Bastian. Nature 2009
983
8

Improved survival with MEK inhibition in BRAF-mutated melanoma.
Keith T Flaherty, Caroline Robert, Peter Hersey, Paul Nathan, Claus Garbe, Mohammed Milhem, Lev V Demidov, Jessica C Hassel, Piotr Rutkowski, Peter Mohr,[...]. N Engl J Med 2012
8

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
Esther Edlundh-Rose, Suzanne Egyházi, Katarina Omholt, Eva Månsson-Brahme, Anton Platz, Johan Hansson, Joakim Lundeberg. Melanoma Res 2006
246
8

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Keith T Flaherty, Jeffery R Infante, Adil Daud, Rene Gonzalez, Richard F Kefford, Jeffrey Sosman, Omid Hamid, Lynn Schuchter, Jonathan Cebon, Nageatte Ibrahim,[...]. N Engl J Med 2012
8

Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.
Alexander M Menzies, Lauren E Haydu, Lydia Visintin, Matteo S Carlino, Julie R Howle, John F Thompson, Richard F Kefford, Richard A Scolyer, Georgina V Long. Clin Cancer Res 2012
300
8

Mutations in GNA11 in uveal melanoma.
Catherine D Van Raamsdonk, Klaus G Griewank, Michelle B Crosby, Maria C Garrido, Swapna Vemula, Thomas Wiesner, Anna C Obenauf, Werner Wackernagel, Gary Green, Nancy Bouvier,[...]. N Engl J Med 2010
913
8

Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Peter A Kanetsky, Saarene Panossian, David E Elder, DuPont Guerry, Michael E Ming, Lynn Schuchter, Timothy R Rebbeck. Cancer 2010
74
10

Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
C Kennedy, J ter Huurne, M Berkhout, N Gruis, M Bastiaens, W Bergman, R Willemze, J N Bavinck. J Invest Dermatol 2001
293
8

BRAF and NRAS mutations in melanoma and melanocytic nevi.
Jenny N Poynter, James T Elder, Douglas R Fullen, Rajan P Nair, Maria S Soengas, Timothy M Johnson, Bruce Redman, Nancy E Thomas, Stephen B Gruber. Melanoma Res 2006
167
8

MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.
Elena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, Sara Gandini, Patrick Maisonneuve, Vincenzo Bagnardi, Claudia Specchia, Fan Liu, Manfred Kayser, Tamar Nijsten,[...]. Int J Cancer 2015
64
12

Germline MC1R status influences somatic mutation burden in melanoma.
Carla Daniela Robles-Espinoza, Nicola D Roberts, Shuyang Chen, Finbarr P Leacy, Ludmil B Alexandrov, Natapol Pornputtapong, Ruth Halaban, Michael Krauthammer, Rutao Cui, D Timothy Bishop,[...]. Nat Commun 2016
76
10

The Genetic Evolution of Melanoma from Precursor Lesions.
A Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, Aravindhan Sriharan, Eric Talevich, Alexander Gagnon, Reinhard Dummer, Jeffrey North, Laura Pincus, Beth Ruben,[...]. N Engl J Med 2015
517
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.